The NVX-CoV2373 COVID-19 vaccine offers significant protection against symptomatic infections, but its effectiveness against SARS-CoV-2 declines within four months, according to a study in JAMA Network Open using Italian data. However, its protection against symptomatic COVID-19 seems to remain stable during this period.
Unusual Visual Symptoms and Alzheimer’s; Infections and Dementia; Head Trauma and MS
Posterior cortical atrophy — a rare syndrome characterized by progressive visual impairment including constructional dyspraxia, space perception deficit, or simultagnosia — presented as a young-onset
January 24, 2024